Olema Pharmaceuticals (OLMA) FY 2025 Conference May 20, 2025 01:30 PM ET Speaker0 Hi, everyone. Good afternoon. Thanks for joining us at the HC Wainwright BioConnect Conference. I'm pleased to introduce Sean Bowen, who's the chief executive officer of Olima Therapeutics, and I am Emily Bodner, equity research analyst at H. C. Wainwright. Sean, maybe to start off, if you could walk us through a bit about the background on Olima, your lead asset, palisestra, and and the transforming landscape in the ER positi ...